ishadeshpande (1) - PowerPoint PPT Presentation

About This Presentation

ishadeshpande (1)


Growing usage of single-cell sequencing in oncology is one of the significant factors influencing the market growth. – PowerPoint PPT presentation

Number of Views:17
Slides: 13
Provided by: ishadeshpande
Category: Other
Tags: share | size


Transcript and Presenter's Notes

Title: ishadeshpande (1)

Single-Cell Sequencing Market Size Worth USD
3,230.6 Million by 2027
Growing usage of single-cell sequencing in
oncology is one of the significant factors
influencing the market growth.
Our Model
Market Analysis
Financial Analysis
Distribution Channel Analysis
Brand Analysis
Custom Market Intelligence
Competitor Analysis
Product Analysis
Custom Research
Demand Analysis
Risk Analysis
Business Plan Parameters
End Use Analysis
Demand Availability Analytics
Market Entry Strategy
Restructuring Revival
New Product Strategy
Product Planning / Strategy
SWOT Analysis
Marketing / Distribution Channel Feasibility
Customer Identification Survey
Competitive Landscape / MA Feasibility
Industries We Cater to
Market Summary
The global single-cell sequencing market is
expected to reach USD 3,230.6 Million by 2027,
according to a new report by Emergen Research.
Single-cell sequencing finds widespread use in
resolving heterogeneity of tumor, reconstruction
of cancer cell evolutionary courses, and
identification of rare sub-clones, thereby
providing a promising technique for addressing
resistance to drugs. Recently, researchers at
the University of South California (USC) have
developed a method using single-cell sequencing
to identify sub-clones in cancer tissue that
could provide important biological insights into
how cancer progresses, how it spreads, and why it
can become resistant to treatment.
Market Summary
  • Some Key Highlights From the Report
  • Single-cell isolation aids in achieving cell
    viability of 99.0 without interfering with whole
    genome amplification, polymerase chain reaction
    (PCR), or whole transcriptome amplification (WTA)
    reactions and therefore held a substantial share
    of the market in 2019.
  • The next-generation sequencing (NGS) technology
    has drawn the attention of many companies and
    investors in various fields, including
    fundamental research, discovery, and production
    of pharmaceutical drugs, reproductive, and
    consumer genomics.
  • Key participants include Illumina, Thermo Fisher
    Scientific Inc., Fludigim, Bio-Rad, Becton,
    Dickinson, and Company, Qiagen, F Hoffmann-La
    Roche Ltd., BGI, 10X Genomics Inc., Oxford
    Nanopore Technologies, among others.
  • In January 2020, Illumina made an announcement
    that scientists at Weizmann Institute of Science
    in Israel, a leader in single-cell genomics,
    would use NGS technology by Illumina.
  • Request Free Sample Copy_at_ https//www.emergenresea
Market Summary
Emergen Research has segmented the global
single-cell sequencing market on the basis of
product type, workflow, technology, disease type,
application, end-use, and region Product Type
Outlook (Revenue, USD Billion 2017-2027) Reagents
Instruments Workflow Outlook (Revenue, USD
Billion 2017-2027) Single Cell Isolation Sample
Preparation Genomic Sequencing Read More_at_
Parameter Details
Market Size Estimation Period 2020-2028
Base Year Considered 2020
Historical Data 2017-2019
Forecast Period 2021-2028
Quantitative Units Revenue in USD million CAGR from 2020 to 2028
Segments Covered Types, Application, End-Users, Regions more.
Countries Included The U.S., Germany, U.K., Italy, China, India, Japan, Brazil
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Regions Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Customization Scope 10 hours of free customization expert consultation
Pricing and Purchase Options Explore Different Purchase Options Request for Discount to Avail New Year Discount
Regional Share Dynamics
Latest published reports from the Healthcare
Sector by Emergen Research 3D Bioprinting
Market_at_ https//
eport/3d-bioprinting-market Gene Editing Market
_at_ https//
gene-editing-market Continuous Glucose
Monitoring System Market_at_ https//www.emergenresea
ing-system-market Hearing Aids Market_at_
aring-aids-market Smart Contact Lens Market_at_
About Us
At Emergen Research, we believe in advancing with
technology. We are a growing market research and
strategy consulting company with an exhaustive
knowledge base of cutting-edge and potentially
market-disrupting technologies that are predicted
to become more prevalent in the coming
decade. Our expertise umbrellas the
technological environment of all major
industries, and our services help you map your
actions to ensure optimal yield. Our analysts
utilize their market proficiency to offer
actionable insights that help our clients
implement profitable strategies and optimize
their return on investment. Our services are
wide-ranging, right from technological
environment analysis to technological profiling
that highlights the existing opportunities in the
market you can capitalize on to stay ahead of
your competitors.
Lets Talk Contact Information
Reach out to us and our Research Executives will
ensure you get the report that meets all your
requirements and address all your concerns.
14671 110 Avenue, Surrey, British Columbia, V3R2A9
1 (604) 757-9756
Write a Comment
User Comments (0)